FdaApplication
ANDA 207619
Identifiers
- fda_app_no: ANDA207619
Properties
| Property | Value |
|---|---|
| applicant_name | BRECKENRIDGE PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2022-06-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CABAZITAXEL | CABAZITAXEL | 60MG/1.5ML (40MG/ML) | SOLUTION;INTRAVENOUS |
1 product